The content on this site is intended for healthcare professionals only
Dr Alexandria Leary delivers her presentation on novel therapies and combinations in ovarian cancer.
BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer
The added value of integrative medicine
Unlocking the potential of liquid biopsy applications in personalised care for older adults with cancer
New classification for identifying HR myeloma based on cytogenetic abnormalities
ESMO 2024: Optimising the personalisation of prostate cancer treatment
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
Best practice in HRRm testing in patients with metastatic prostate cancer
Multiple myeloma in a resource constrained setting
